Search results
Daphne Koller is CEO and founder of insitro, a machine learning-driven drug discovery and development company transforming the way drugs are discovered and delivered to patients.
Daphne Koller founded insitro with the audacious goal to use the power of AI to revolutionize drug discovery. Don’t miss her interview with Paul…
- insitro
Oct 25, 2023 · Koller explained a two-step process that can lead to novel drug targets for cancer. In the first step, Insitro machine learning AI technology is able to analyze images of cancerous tissue, a ...
CEO and Founder, insitro - Cited by 111,657 - machine learning - computational biology - computer vision - artificial intelligence
Our CEO Daphne Koller founded insitro in 2018 to harness these developments on behalf of the many patients in need. Learn more about our founding story from Daphne’s blog post.
Nov 11, 2019 · Can a giant pile of data beat human expertise in the design of miracle drugs? Daphne Koller and her startup Insitro may come up with a surprising answer.
Daphne Koller. CEO & Founder. A Team Greater Than the Sum of Its Parts. We’ve built a unique culture where life scientists, data scientists, engineers, and drug hunters work together to identify the most important questions, design and scale experiments, build models, and analyze the results.
